Hematologic Malignancies

Expert faculty review and share their insights and perspectives on key findings in hematologic malignancies presented at the 2022 ASCO Annual Meeting.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie

AstraZeneca

Gilead Sciences, Inc.

Novartis Pharmaceuticals Corporation

Seagen